(Health-NewsWire.Net, May 27, 2016 ) Publisher's, 'Anacor Pharmaceuticals, Inc. - Pipeline Review, H1 2016', provides an overview of the Anacor Pharmaceuticals, Inc. pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Anacor Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Anacor Pharmaceuticals, Inc. and features dormant and discontinued projects.
Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Anacor Pharmaceuticals, Inc. - The report reviews pipeline therapeutics for Anacor Pharmaceuticals, Inc. by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Anacor Pharmaceuticals, Inc. therapeutics and enlists all their major and minor projects - The report assesses Anacor Pharmaceuticals, Inc. therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report summarizes all the dormant and discontinued pipeline projects - The report reviews latest news related to pipeline therapeutics for Anacor Pharmaceuticals, Inc.
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001242081/sample
Table of Content: An Overview
Table of Contents 2 List of Tables 5 List of Figures 5 Anacor Pharmaceuticals, Inc. Snapshot 6 Anacor Pharmaceuticals, Inc. Overview 6 Key Information 6 Key Facts 6 Anacor Pharmaceuticals, Inc. - Research and Development Overview 7 Key Therapeutic Areas 7 Anacor Pharmaceuticals, Inc. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Out-Licensed Products 12 Out-Licensed Products/Combination Treatment Modalities 13 Anacor Pharmaceuticals, Inc. - Pipeline Products Glance 14 Anacor Pharmaceuticals, Inc. - Late Stage Pipeline Products 14 Pre-Registration Products/Combination Treatment Modalities 14 Anacor Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 15 Phase II Products/Combination Treatment Modalities 15 Phase I Products/Combination Treatment Modalities 16 Anacor Pharmaceuticals, Inc. - Early Stage Pipeline Products 17 Preclinical Products/Combination Treatment Modalities 17 Discovery Products/Combination Treatment Modalities 18 Anacor Pharmaceuticals, Inc. - Drug Profiles 19 crisaborole 19 Product Description 19 Mechanism of Action 19 R&D Progress 19
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001242081/discount
epetraborole 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 AN-2718 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 AN-3485 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 AN-4161 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 AN-4169 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 AN-5973 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Small Molecule 1 for Tuberculosis 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Small Molecule 2 for Tuberculosis 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 Small Molecule for Shigellosis 30 Product Description 30 Mechanism of Action 30 R&D Progress 30
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001242081/buy/1500
About Us:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us: Email: sales@reportsweb.com Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|